CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2014
Licensing Revenue	$ 75,000	$ 75,000	$ 100,000
Operating expenses:
General and administrative	1,606,043	3,170,499	3,683,350
Research and development	2,182,989	4,568,435	3,338,687
Acquisition Costs	0	0	544,978
Impairment of goodwill	5,780,951	8,121,966	0
Impairment of acquired R&D	1,700,000	0	0
Impairment and write-off of patents	0	2,290,836	1,680,781
Total operating expenses	11,269,983	18,151,736	9,247,796
Loss from operations	(11,194,983)	(18,076,736)	(9,147,796)
Other non-operating income (expense)
Change in fair value of stock right	254,027	12,405	0
Change in fair value of warrant liability	1,993,560	3,313	0
Interest expense	(533)	(2,767)	(77,438)
Net loss before income tax benefit	(8,947,929)	(18,063,785)	(9,225,234)
Income tax benefit	680,000	0	0
Net Loss	(8,267,929)	(18,063,785)	(9,225,234)
Preferred dividends	(179,154)	(838,925)	(4,629,197)
Loss applicable to common shares	(8,447,083)	(18,902,710)	(13,854,431)
Other comprehensive loss	0	0	0
Comprehensive loss	$ (8,447,083)	$ (18,902,710)	$ (13,854,431)
Basic and diluted net loss per common share	$ (0.42)	$ (1.31)	$ (2.53)
Basic and diluted weighted-average number of common shares outstanding	20,322,714	14,417,029	5,476,717